Happy Friday! Here is what I am reading as we head into the weekend: Talk about hitting on a lot of points, super insightful article - Regeneron’s Billionaire Founder Battles The Drug Pricing System (Forbes). Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups (Xconomy) When healthcare devices go over the counter. An important … Continue reading Friday Morning’s Top Articles
Tag: Alzheimer’s
Thursday Morning Headlines
Yesterday was dominated by Biogen's news on their Alzheimer drug, but there was other news including Sarepta getting slapped with a clincial hold, Gilead CEO stepping down and, although not Life Science related, Facebook getting crushed after their earnings. Here is what I'm reading: Yesterday afternoon Eisai & Biogen Revealed Promising Alzheimer’s Data But Questions … Continue reading Thursday Morning Headlines
Wednesday Morning Headlines
Here is what I am reading this morning: Glaxo’s New Research Chief Loves Big Pharma. Now He Has To Fix It (Forbes) – Highly recommended read! 23andMe is raising up to $300M on top of what they have already raised, valuing them at $2.5B (PitchBook). Venture capital firms invested more than $738 million in Medtech … Continue reading Wednesday Morning Headlines
MattCorc 